GridAI Technologies (GRDX) Share-based Compensation (2016 - 2025)
GridAI Technologies' (GRDX) quarterly Share-based Compensation came in at $733950.0 in Q4 2025, up 1543.45% YoY from $44659.0 in Q4 2024, and up 1543.45% on a QoQ basis from $44659.0 in Q4 2024.
GridAI Technologies (GRDX) Share-based Compensation (2016 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 10 years of Share-based Compensation data on file, last reported at $733950.0 in Q4 2025.
- Quarterly Share-based Compensation rose 1543.45% year-over-year to $733950.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $778609.0 (up 24.37% YoY) and the FY2025 annual result came in at $733950.0, up 16.21% from the prior year.
- Share-based Compensation rose to $733950.0 in Q4 2025, from $44659.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.5 million in Q1 2021 to a low of $44659.0 in Q4 2024.
- A 5-year average of $571853.0 and a median of $292704.0 in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation surged 1622.06% — and 2022, when it slumped 92.07%.
- Tracing GRDX's Share-based Compensation over 5 years: stood at $110203.0 in 2021, then jumped by 489.94% to $650134.0 in 2022, then tumbled by 80.6% to $126122.0 in 2023, then slumped by 64.59% to $44659.0 in 2024, then surged by 1543.45% to $733950.0 in 2025.
- The last three Share-based Compensation figures came in at $733950.0 (Q4 2025), $44659.0 (Q4 2024), and $183646.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 733,950.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 733,950.00 |
| Dec 31, 2025 | 733,950.00 |
| Dec 31, 2024 | 44,659.00 |
| Dec 31, 2024 | 44,659.00 |
| Sep 30, 2024 | 183,646.00 |
| Sep 30, 2024 | 183,646.00 |
| Jun 30, 2024 | 126,394.00 |
| Jun 30, 2024 | 126,394.00 |
| Mar 31, 2024 | 271,360.00 |
| Mar 31, 2024 | 271,360.00 |
| Dec 31, 2023 | 126,122.00 |
| Dec 31, 2023 | 126,122.00 |
| Sep 30, 2023 | 263,330.00 |
| Sep 30, 2023 | 263,330.00 |
| Jun 30, 2023 | 292,704.00 |
| Jun 30, 2023 | 292,704.00 |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 650,134.00 |
| Dec 31, 2022 | 650,134.00 |